SMK Corporation FY2027 Q1 Earnings Report

Quick View

Executive Summary

The core point of this earnings report is that operating income was nearly breakeven, while the growth in ordinary income and net income was heavily dependent on non-operating income. Revenue was ¥114.7B (+4.0% YoY), operating income was ¥0.1B (a return to profitability from ¥-2.8B in the previous year), ordinary income was ¥3.1B (+149.7%), and net income was ¥1.5B (+123.7%). While the increase in revenue was driven by the expansion of the CS Business Division, the absolute level of operating income remains low, and the growth in ordinary income was supported by non-operating income, including equity-method investment income and foreign exchange gains.

Factors Affecting Earnings

【Revenue】Revenue was ¥114.7B, up +4.0% YoY. By segment, the CS Business Division was the primary source of revenue growth, with revenue of ¥58.8B (+12.9%), while the SCI Business Division recorded a decline in revenue to ¥55.9B (-3.6%). RandD Center generated almost no revenue, remaining at ¥0.0B (-90.0%).

【Profit and Loss】Operating income was ¥0.1B (¥-2.8B in the previous year), marking a return to profitability, while the operating margin remained at just 0.1%. The CS Business Division reported operating income of ¥2.7B (4.6% margin), representing an increase in profit. The SCI Business Division reported an operating loss of ¥1.9B, but the loss narrowed from ¥3.7B in the previous year. Ordinary income was ¥3.1B (+149.7%), primarily because non-operating income of ¥5.3B (including equity-method investment income of ¥1.1B, dividend income of ¥0.3B, and foreign exchange gains of ¥0.2B, among others) exceeded non-operating expenses of ¥2.3B. An impairment loss of ¥0.2B was recorded as an extraordinary loss, resulting in profit before tax of ¥2.9B and net income of ¥1.5B after an effective tax rate of 46.2%. Revenue and profit both increased.

Segment Analysis

The CS Business Division recorded revenue of ¥58.8B (+12.9% YoY), operating income of ¥2.7B (+17.5%), and a 4.6% margin, achieving higher revenue and profit and serving as the main contributor to consolidated earnings. The SCI Business Division recorded lower revenue of ¥55.9B (-3.6% YoY), but its operating loss narrowed to ¥1.9B from ¥3.7B in the previous year. RandD Center recorded an operating loss of ¥0.7B against revenue of ¥0.0B, with upfront investment related to research and development placing pressure on consolidated profit. Achieving profitability in the SCI Business Division, which accounts for approximately half of consolidated revenue, is the most important issue for improving operating income going forward.

Key Financial Metrics

【Profitability】The operating margin was 0.1%, while the net profit margin turned positive at 1.3% (△5.9% in the previous year), although the absolute level remains low. The gross margin was 19.9% and the SG&A expense ratio was 19.8%, almost equal to each other, indicating that nearly all gross profit was absorbed by SG&A expenses.【Cash Flow Quality】Of ordinary income of ¥3.1B, net non-operating income accounted for ¥3.0B, indicating a significant contribution from sources outside the core business.【Investment Efficiency】ROE was 0.5% and the equity ratio was 52.6% (54.1% in the previous year), indicating that capital efficiency remains low.【Financial Soundness】Current assets were ¥324.2B compared with current liabilities of ¥164.1B, resulting in a current ratio of approximately 2x and providing a substantial liquidity cushion. However, interest expense was ¥0.7B against operating income of only ¥0.1B, indicating a low interest coverage ratio.

Cash Flow Analysis

As no cash flow statement has been disclosed, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits increased to ¥110.2B from ¥96.7B in the previous year, and funding conditions are generally stable. Inventories increased to ¥30.8B from ¥27.2B in the previous year, while raw materials increased to ¥42.1B from ¥34.0B, indicating an accumulation of working capital. Short-term borrowings were ¥71.1B and long-term borrowings were ¥68.3B, bringing total interest-bearing debt to ¥139.4B, an increase YoY. Cash balances exceed short-term borrowings, and there are no significant near-term concerns regarding liquidity.

Quality of Earnings

Of ordinary income of ¥3.1B, operating income accounted for only ¥0.1B, with the majority generated by non-operating income of ¥5.3B. Non-operating income included equity-method investment income of ¥1.1B, dividend income of ¥0.3B, and foreign exchange gains of ¥0.2B, along with many items that differ in nature from the recurring earning power of the business. An impairment loss of ¥0.2B was recorded as an extraordinary loss, meaning that part of net income of ¥1.5B reflects temporary adjustments. Comprehensive income was ¥4.6B, exceeding net income of ¥1.5B. The difference was attributable to valuation-related items, including foreign currency translation adjustments of ¥3.3B and valuation differences on securities of ¥0.9B. Accordingly, the improvement in earnings for the current period was highly dependent on non-operating income and valuation-related items and should be distinguished from an improvement in earning power generated by the core business.

Earnings Forecast and Guidance

The full-year plan calls for revenue of ¥490.0B (+1.7% YoY), operating income of ¥8.0B (+86.0%), and ordinary income of ¥12.0B (-3.5%), with no revision to the earnings forecast. While the Q1 progress rates for revenue and ordinary income were generally standard at 23.4% and 25.6%, respectively, operating income was only ¥0.1B, representing a substantially low progress rate of approximately 1%. Achieving the full-year operating income plan will require continued profit growth in the CS Business Division and a return to profitability in the SCI Business Division from Q2 onward.

Shareholder Returns

The full-year dividend forecast remains ¥100 per share, with no revision. The payout ratio against forecast EPS of ¥126.41 is approximately 79.1%, above the general benchmark of 60%. The coverage multiple of total dividends against the full-year net income plan is approximately 1.26x, indicating that the dividend level is structurally dependent on the degree to which the operating income plan is achieved. The progress rate for Q1 net income was only 19.3%, making achievement of the full-year plan a prerequisite for dividend sustainability.

Risk Factors

1. Weak profitability in the SCI Business Division: The SCI Business Division, which accounts for approximately 49% of consolidated revenue, recorded an operating loss of ¥1.9B and a margin of △3.4%. Although the loss narrowed from the previous year, a delay in recovery would hinder improvement in consolidated operating income.

2. Insufficient interest payment capacity due to low profitability: Interest expense of ¥0.7B exceeded operating income of ¥0.1B, indicating that the company is unable to cover interest payments with core business profit. Short-term borrowings account for more than half of interest-bearing debt of ¥139.4B, at ¥71.1B, and refinancing terms will depend on the degree of recovery in core business earnings.

3. Low gross margin and sensitivity to margin fluctuations: The gross margin of 19.9% is below 20%, while the operating margin is extremely thin at 0.1%. As a result, fluctuations in costs or the ability to pass through prices could easily reverse the company’s profit or loss position.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability is substantially below the industry median.

Growth and Capital Efficiency

Revenue growth is also slightly below the industry median, and both growth and profitability are relatively low within the industry.

※Source: Compiled by the Company

Key Points from the Earnings Report

1. The increase in profit this period is a fact, but net non-operating income was substantial at ¥3.0B compared with an operating margin of 0.1%, indicating that the quality of earnings improvement remains underdeveloped in terms of the core business.

2. The CS Business Division achieved higher revenue and profit and became the main contributor to consolidated earnings. Meanwhile, although the SCI Business Division narrowed its loss, it remains a large loss-making business, making the timing of its return to profitability the key to improving consolidated operating income.

3. The full-year dividend forecast of ¥100 represents a payout ratio of approximately 79.1% against forecast EPS. With Q1 operating income progress remaining below 1%, monitoring progress toward achievement of the full-year plan is an important issue.

Theoretical Stock Price (Reference Value)

Sensitivity: ¥3,930–¥4,148 at ±1% for the cost of equity, and ¥4,009–¥4,054 at ±0.1 for ω.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing mismatch with the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market stock price or a recommendation of any specific investment action, nor does it predict or guarantee future stock prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmark is reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional adviser as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

SMK delivered a marked year-on-year earnings recovery in FY2027 Q1, but the turnaround remains fragile because operating profitability was close to break-even. Revenue rose 4.0% YoY to ¥11.47bn. Operating income improved to ¥0.06bn from a ¥2.80bn operating loss in the prior-year quarter. Ordinary income reached ¥3.07bn, compared with a ¥6.18bn loss previously. Net income attributable to owners was ¥1.54bn, versus a ¥6.51bn loss a year earlier. The gross margin expanded to 19.9% from 17.5% in the prior-year quarter, an improvement of approximately 240bp. The operating margin improved by approximately 260bp YoY, from negative 2.5% to 0.1%, but remains materially below a sustainable manufacturing profitability level. SG&A expenses increased 2.6% YoY to ¥2.27bn, slower than revenue growth, which supported the return to operating profit. The CS business was the core business by operating-income contribution, generating ¥5.88bn of sales and ¥0.27bn of segment profit. SCI remained loss-making, although its segment loss narrowed substantially. Reported ordinary income was supported predominantly by non-operating income of ¥0.53bn, which was nearly 87 times quarterly operating income. Equity-method earnings of ¥0.11bn and net foreign-exchange gains of ¥0.25bn were meaningful contributors to pre-tax profitability. The ¥0.02bn impairment loss was small in absolute terms but represents a non-recurring charge against a thin operating-profit base. Comprehensive income of ¥4.60bn exceeded net income, aided by positive foreign currency translation and securities valuation movements. Liquidity is adequate, with a 197.6% current ratio and cash of ¥11.02bn exceeding short-term loans of ¥7.11bn. However, annualized ROE was only 2.0%, reflecting insufficient operating returns despite moderate financial leverage. The full-year plan implies a substantial acceleration in operating income after Q1, making the trajectory of CS profitability, SCI loss reduction, foreign exchange, receivables and debt servicing central to the FY2027 outlook.

Profitability Analysis

Annualized DuPont ROE is 2.0%, comprising a 1.3% net profit margin, 0.772x asset turnover and 1.90x financial leverage. The weak component is the net margin: even after returning to profit, earnings generation remains very low relative to the ¥59.45bn asset base. Asset turnover is reasonable for the current balance-sheet structure, while leverage is moderate rather than aggressive, with debt-to-equity of 0.90x. Consequently, the company cannot rely on greater leverage to create acceptable shareholder returns; a durable recovery in operating margin is required. Gross profit increased 17.8% YoY to ¥2.28bn, considerably faster than the 4.0% revenue increase, lifting gross margin by approximately 240bp to 19.9%. This gross-profit improvement was the principal operational driver of the turnaround. SG&A rose only 2.6% YoY, below sales growth, indicating modest positive operating leverage. Nevertheless, SG&A consumed virtually all gross profit, leaving only ¥0.006bn of operating income and a 0.1% EBIT margin. The low operating-efficiency alert is therefore material: a small adverse movement in pricing, input costs, production utilization or mix could return the group to operating losses. Interest coverage was only 0.09x, because quarterly EBIT of ¥0.006bn was well below ¥0.069bn of interest expense. This is a debt-service concern despite the positive ordinary-income result, because non-operating gains rather than operating earnings covered financing costs. The 46.2% effective tax rate produced a tax burden of 0.538, below the normal 0.70-plus range and reduced conversion of pre-tax income into net income. The CS business posted a 4.6% segment margin, with sales up 12.9% YoY and segment profit up 17.5% to ¥0.27bn. SCI sales declined 3.6% to ¥5.59bn, but its segment loss narrowed to ¥0.19bn from ¥0.37bn; its margin improved by roughly 320bp to negative 3.4%. The Innovation Center recorded a ¥0.07bn loss on negligible external sales. The earnings recovery is therefore operationally credible at the gross-profit level, but the operating-margin base is not yet sufficient to regard the improvement as established.

Growth Assessment

Revenue growth of 4.0% was led by the CS business, where sales increased ¥0.67bn YoY. CS also increased segment profit by ¥0.04bn, preserving a positive earnings contribution. SCI's 3.6% sales decline remains a constraint on group growth, although the ¥0.18bn reduction in segment loss is a significant improvement in profit quality. Group gross profit grew ¥0.35bn YoY, indicating that mix, pricing, procurement conditions or production efficiency improved more than revenue alone would suggest. The main sustainability question is whether the gross-margin recovery can be retained while further reducing SCI losses. Full-year revenue guidance is ¥49.0bn, implying Q1 progress of 23.4%, only 1.6 percentage points below the standard 25% first-quarter pace. Full-year operating-income guidance is ¥0.80bn, while Q1 operating income was only ¥0.006bn, equivalent to 0.8% progress versus the standard 25%. Full-year ordinary-income guidance is ¥1.20bn, and Q1 ordinary income represents 25.6% progress, broadly consistent with the standard first-quarter pace. Full-year net-income guidance is ¥0.80bn, and Q1 net income represents 19.3% progress, below the standard pace. The divergence between ordinary-income and operating-income progress indicates that the annual plan depends on a major improvement in underlying operations during the remaining nine months. Full-year guidance calls for a 1.7% revenue increase and an 86.0% increase in operating income, reinforcing the need for margin expansion rather than sales growth alone. The forecast annual operating margin is approximately 1.6%, above Q1's 0.1% but still modest. The company has not revised either its earnings forecast or dividend forecast. Foreign-exchange gains of ¥0.25bn were 416.7% of operating income, so exchange-rate movements can materially affect reported profit while operating income remains this low. The most relevant operating indicators are CS margin resilience, SCI's path to break-even, gross-margin retention and the conversion of revenue growth into EBIT.

Financial Health

Liquidity is healthy on a static balance-sheet basis. Current assets of ¥32.42bn exceeded current liabilities of ¥16.41bn, resulting in working capital of ¥16.01bn and a current ratio of 197.6%. The quick ratio was also strong at 178.8%, supported by cash and deposits of ¥11.02bn and receivables. Cash covered 1.55x short-term loans, providing an important near-term refinancing buffer. Total interest-bearing debt was ¥13.94bn, consisting of ¥7.11bn of short-term loans and ¥6.83bn of long-term loans. The short-term debt ratio of 51.0% is high and creates refinancing risk because more than half of borrowings require near-term funding access. Debt-to-equity of 0.90x and debt-to-capital of 30.8% are within conservative covenant-style thresholds and do not indicate excessive balance-sheet leverage. Total equity was ¥31.30bn, up modestly from ¥31.16bn a year earlier, while the equity ratio declined to 52.6% from 54.1% as assets and liabilities expanded. The key credit weakness is not the level of debt relative to capital, but the inability of Q1 EBIT to service interest expense. Accounts payable increased 38.4% YoY to ¥4.00bn, exceeding the 25% notable-change threshold. The increase partly financed working capital and improved near-term liquidity, but may also reflect higher purchasing activity, payment timing or supplier-credit utilization. Accounts receivable were ¥9.50bn, with electronically recorded monetary claims of ¥2.36bn additionally reported. The annualized DSO alert of 76 days is above the 60-day warning level, indicating comparatively slow collection and elevated working-capital intensity. Property, plant and equipment represented 24.3% of total assets, while land alone was ¥5.82bn, giving the balance sheet a meaningful fixed-asset component. The capital structure is presently liquid, but its resilience depends on restoring operating cash generation and EBIT-based interest coverage.

Notable B/S Changes

Accounts payable: +¥1.11bn (+38.4% YoY) to ¥4.00bn - increased supplier financing supports near-term working capital, but payment terms and procurement-related cash use should be monitored.

Cash Flow Quality

The current data set does not provide operating, investing or financing cash-flow totals, so cash conversion, free cash flow, OCF-to-net-income coverage and cash funding of investment commitments cannot be quantified. Earnings quality can nevertheless be assessed from the income statement and working-capital structure. Net income of ¥1.54bn was substantially above operating income of ¥0.006bn because non-operating income of ¥0.53bn outweighed non-operating expenses of ¥0.23bn. Equity-method earnings contributed ¥0.11bn, dividend income contributed ¥0.03bn, interest income ¥0.02bn and foreign-exchange gains ¥0.25bn. These items supported reported earnings but are not equivalent to a broad-based recovery in core manufacturing profitability. The ¥0.02bn impairment loss reduced pre-tax income and is non-recurring, although it is immaterial relative to net income. Receivables and electronically recorded monetary claims totalled ¥11.87bn, and the elevated 76-day DSO alert makes collection discipline important for cash conversion. Inventories reported on the balance sheet were ¥3.08bn, while manufacturing disclosures also identify raw materials of ¥4.21bn and work in process of ¥0.77bn; management should be assessed on the evolution of production and inventory funding alongside reported working-capital balances. Accounts payable increased ¥1.11bn YoY, providing a short-term source of operating funding. This supplier-financing benefit should not be treated as a substitute for sustainably positive operating cash flow. The central earnings-quality issue is the gap between near-break-even EBIT and positive net income, which leaves cash-generation quality highly sensitive to working-capital movements and non-operating gains.

Dividend Sustainability

The company forecasts an FY2027 dividend per share of ¥100. Based on forecast EPS of ¥126.41, the implied dividend payout ratio is approximately 79.1%. This is above the 60% sustainability benchmark and leaves a limited earnings retention buffer for a company with low operating profitability and meaningful debt. The projected cash dividend is approximately ¥0.63bn when applied to the Q1 weighted-average share count of 6.33 million shares. This compares with full-year forecast net income of ¥0.80bn, again indicating a relatively high distribution commitment. Q1 EPS was ¥24.40, so the planned full-year DPS requires a substantial increase in earnings through the remainder of the year. The prior-year disclosed dividend per share was ¥50, making the FY2027 planned ¥100 dividend a significant step-up. The balance sheet provides near-term support through ¥11.02bn of cash, but dividend durability should be judged primarily against recurring operating profit and cash flow rather than cash balances or foreign-exchange gains. With Q1 operating income of only ¥0.006bn, execution against the ¥0.80bn full-year operating-income target is important to support the planned payout. No dividend revision has been announced. The policy outlook is therefore dependent on sustained CS earnings, SCI loss reduction, collection of receivables and an improvement in interest coverage.

Risk Assessment

Business risks include Operating-margin risk: the 0.1% Q1 EBIT margin leaves profits highly exposed to pricing pressure, input-cost inflation, factory utilization changes and adverse product mix., SCI execution risk: SCI remained loss-making at negative ¥0.19bn despite a ¥0.18bn YoY improvement, and a return to break-even is necessary for the full-year operating plan., Foreign-exchange risk: ¥0.25bn of FX gains equalled 416.7% of operating income, demonstrating that currency movements can dominate reported quarterly profitability., Collection-cycle risk: the 76-day annualized DSO exceeds the 60-day warning level and can constrain operating cash conversion., Manufacturing-cycle risk: demand volatility, component procurement conditions, raw-material pricing, customer concentration and inventory planning can quickly affect a business operating at a very low margin..

Financial risks include Debt-service risk is high: interest coverage was only 0.09x, meaning Q1 EBIT did not cover interest expense., Refinancing risk is elevated because ¥7.11bn of short-term loans represented 51.0% of interest-bearing debt., The effective tax rate of 46.2% reduced net-income conversion, with a tax burden of 0.538., The planned ¥100 DPS implies a 79.1% forecast payout ratio, limiting retained earnings available for deleveraging and investment..

Key concerns include Highest priority is the large gap between Q1 operating-income progress of 0.8% and the normal 25% first-quarter progress benchmark for the full-year operating-income forecast., The earnings recovery is supported by non-operating income, particularly FX gains and equity-method income, rather than a sufficiently strong core EBIT base., The 38.4% YoY increase in accounts payable should be monitored alongside receivables and inventory to determine whether working capital remains a source of cash or becomes a funding requirement., Gross margin improved to 19.9% but remains just below the 20% alert threshold; preserving and expanding this margin is essential for operating leverage., The low annualized ROE of 2.0% and ROIC alert of 0.0% indicate weak capital efficiency..

Investment Implications

Key takeaways include Q1 marks a substantial YoY recovery, with operating, ordinary and net income all turning positive., CS is the earnings anchor, with ¥0.27bn of segment profit and a 4.6% segment margin., SCI's narrowing loss is encouraging, but it remains the principal operating drag., Core profitability remains weak because Q1 operating income was only ¥0.006bn despite ¥11.47bn of revenue., Liquidity and debt-capital ratios are acceptable, but EBIT-based debt service is inadequate., The full-year plan requires a pronounced improvement in operating earnings after Q1..

Metrics to watch include Quarterly operating margin and gross margin, CS segment sales growth and segment margin, SCI segment-loss reduction and timing of break-even, Interest coverage and the mix of short-term versus long-term debt, Annualized DSO and movements in receivables, electronic claims and accounts payable, Foreign-exchange gains or losses relative to operating income, Progress toward ¥0.80bn full-year operating income and ¥0.80bn net income, Dividend coverage against recurring earnings and cash generation.

Regarding relative positioning, SMK currently appears balance-sheet-liquid but earnings-light: its 197.6% current ratio, 0.90x debt-to-equity ratio and 30.8% debt-to-capital ratio compare favorably with stressed leverage profiles, whereas its 0.1% operating margin, 2.0% annualized ROE, 0.09x interest coverage and 76-day DSO are weak for an electronics manufacturing company. Relative performance will depend less on balance-sheet expansion and more on converting the Q1 gross-margin recovery and SCI restructuring progress into recurring EBIT.